The prevention that pays for itself is the part they’re cutting.
Most preventive care does not save money — and we say so plainly. But the specific interventions that provably do are exactly the ones under attack.
This is the honest version of an argument that is usually oversold. We give up the blanket claim, and keep the part that survives the evidence: childhood immunization and harm reduction save money, at enormous scale, and they are being defunded anyway.
What this page is about
“Preventive care saves money” is a claim that mostly is not true, and a landmark New England Journal of Medicine analysis said so: most preventive services improve health but do not pay for themselves, and some cost more than they save. We do not make the blanket claim.
We make the narrower one that holds. The CDC found that routine childhood immunization saved about $540 billion in direct costs and $2.7 trillion in societal costs for U.S. children born from 1994 to 2023. And the CDC finds that syringe services programs are cost-saving, because preventing one HIV or hepatitis C infection avoids a lifetime of treatment. Those are the specific things being cut.
The same investigation, restaged one beat at a time. Step through it here, or present it fullscreen.
The prevention that pays for itself is the part they're cutting.
Most preventive care doesn't save money — and we say so. But the specific interventions that provably do, childhood immunization and harm reduction, are exactly the ones under attack.
The short list that pays for itself
The reason these save money and most prevention does not is that they head off catastrophically expensive outcomes — lifelong disease, hospitalization, death — at very low unit cost.
| Intervention | Net effect on cost |
|---|---|
| Routine childhood immunization (1994–2023 cohorts) | ~$540B direct / ~$2.7T societal net savings (CDC) |
| Syringe services / harm reduction | Cost-saving — averts lifetime HIV/HCV treatment (CDC) |
| “Preventive care” in general | Usually NOT cost-saving (NEJM) — we don’t claim it is |
Sources: CDC MMWR (2024) on routine childhood immunization; CDC/HIV.gov on syringe services; Cohen et al., NEJM (2008) on the limits of prevention-as-savings.
The record, claim by claim
Most preventive care does NOT save money — we say so first.
FACTA widely cited analysis by Cohen, Neumann, and Weinstein in the New England Journal of Medicine examined hundreds of preventive measures and found that the majority improve health but do not pay for themselves; some cost more than they save. The lesson is not that prevention is worthless — it often buys health at a reasonable price — but that 'prevention saves money' is not a general truth. We put this at the top on purpose, because the honest case is stronger than the oversold one.
Childhood immunization is a massive net saver — by the CDC's own accounting.
FACTThe CDC's Morbidity and Mortality Weekly Report estimated that routine childhood immunization of U.S. children born between 1994 and 2023 produced net savings of about $540 billion in direct costs and $2.7 trillion in societal costs — after subtracting the cost of the immunization program itself — while preventing hundreds of millions of illnesses, tens of millions of hospitalizations, and hundreds of thousands of deaths. From both the payer and societal perspectives, the CDC concludes it is cost-saving. This is one of the clearest net-positive public investments the government measures, and the Vaccines for Children program that delivers much of it is exactly the kind of access funding now under pressure.
Harm reduction saves money because a prevented infection is a lifetime of treatment avoided.
FACTThe CDC finds that syringe services programs are safe, effective, and cost-saving. The economics are stark: preventing a single HIV infection avoids a lifetime treatment cost that runs into the hundreds of thousands of dollars, and hepatitis C treatment is similarly expensive, so the low cost of sterile equipment and naloxone is repaid many times over. These programs also distribute overdose-reversing naloxone and link people to treatment. This is prevention that pays for itself — and it is repeatedly targeted for defunding on moral rather than fiscal grounds.
Where the evidence is strong, and where we hold the line
- We concede the overclaim. “Preventive care saves money” is mostly false, and we lead with the source that says so. That concession is what makes the rest of the page credible.
- The net-savers are specific and proven. Childhood immunization and harm reduction clear the bar by the government’s own numbers. We name those, not “prevention” in the abstract.
- The cut targets the wrong list. The austerity logic falls hardest on vaccine access and harm reduction — the interventions that actually return money — which is the opposite of a fiscally rational cut.
Cutting the cost-savers, in the name of saving
If the goal were actually to spend less, the last things you would cut are childhood vaccines and harm reduction — the interventions the CDC scores as net-saving hundreds of billions to trillions of dollars. Cutting them is not thrift; it is choosing a more expensive, sicker future for a moral or political point. That is the pattern the Austerity Myth hub documents across every program: the “we can’t afford it” line aimed precisely at the things that pay for themselves.
Questions worth taking seriously
Wait — didn't you just admit preventive care doesn't save money?
Yes, as a blanket claim it usually doesn’t, and we say so with the NEJM source. The point is narrower: specific interventions — childhood immunization and harm reduction — do net-save by the CDC’s own numbers, and those are the ones being cut. We win the honest argument, not the oversold one.
Isn't harm reduction just enabling drug use?
The CDC finds syringe services programs are safe, effective, and cost-saving, and that they link people to treatment rather than away from it. The fiscal fact is independent of the moral debate: preventing an HIV or hepatitis C infection avoids a lifetime treatment bill far larger than the program’s cost.
Are childhood vaccines really that cost-effective?
By the CDC’s own accounting, routine childhood immunization for the 1994–2023 birth cohorts net-saved about $540 billion in direct costs and $2.7 trillion in societal costs, after subtracting program costs, while preventing hundreds of thousands of deaths. It is among the highest-return public investments the government measures.
If you are named on this page
If you are named on this page, or are a party materially affected by the claims made here, and you wish to respond, correct the record, or add context, use the Contact page. Responses are published verbatim alongside the original claim, with the sender identified and the date of receipt. The channel stays open for the life of the page.
This site aggregates and grades a record that other outlets and primary sources have already put on the record. Every FACT-graded claim above is sourced to court filings, government reports, sworn whistleblower disclosures, published investigative journalism, or named-source statements. The citations are the accountability mechanism; this section is how you get on the record too.
The record
- CDC MMWR (2024) — Health and Economic Benefits of Routine Childhood Immunizations, 1994–2023 (~$540B direct / ~$2.7T societal net savings)
- CDC / HIV.gov — Syringe Service Programs Are Safe, Effective, and Cost-Saving
- CDC — Syringe Services Programs (overview; naloxone and treatment linkage)
- Cohen, Neumann & Weinstein — Does Preventive Care Save Money?, New England Journal of Medicine (2008)